Clinical Trial Update: Safety and Efficacy Study of Two Dose Regimens of Becocalcidiol in the Treatment of Plaque-Type Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy study evaluating two dosing regimens of Becocalcidiol for plaque-type psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Becocalcidiol

Snippet

Sponsor: QuatRx Pharmaceuticals Company | Conditions: Psoriasis | Phase 2 | Status: COMPLETED